These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Roumeliotis S; Dounousi E; Eleftheriadis T; Liakopoulos V Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717170 [TBL] [Abstract][Full Text] [Related]
4. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. Shea MK; O'Donnell CJ; Vermeer C; Magdeleyns EJ; Crosier MD; Gundberg CM; Ordovas JM; Kritchevsky SB; Booth SL J Nutr; 2011 Aug; 141(8):1529-34. PubMed ID: 21628633 [TBL] [Abstract][Full Text] [Related]
5. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559 [TBL] [Abstract][Full Text] [Related]
6. Calcium scores and matrix Gla protein levels: association with vitamin K status. Rennenberg RJ; de Leeuw PW; Kessels AG; Schurgers LJ; Vermeer C; van Engelshoven JM; Kemerink GJ; Kroon AA Eur J Clin Invest; 2010 Apr; 40(4):344-9. PubMed ID: 20486996 [TBL] [Abstract][Full Text] [Related]
7. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk. Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491 [TBL] [Abstract][Full Text] [Related]
8. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients. Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985 [TBL] [Abstract][Full Text] [Related]
9. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910 [TBL] [Abstract][Full Text] [Related]
10. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635 [TBL] [Abstract][Full Text] [Related]
12. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope? Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451 [TBL] [Abstract][Full Text] [Related]
13. Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcification. Torii S; Ikari Y; Tanabe K; Kakuta T; Hatori M; Shioi A; Okano T J Nutr Sci; 2016; 5():e48. PubMed ID: 28620475 [TBL] [Abstract][Full Text] [Related]
14. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease. Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S Nephron; 2017; 135(3):167-172. PubMed ID: 27951533 [TBL] [Abstract][Full Text] [Related]
15. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207 [TBL] [Abstract][Full Text] [Related]
16. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study. Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimbürger O; Jørgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P PLoS One; 2021; 16(2):e0247623. PubMed ID: 33626087 [TBL] [Abstract][Full Text] [Related]
17. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk. Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228 [TBL] [Abstract][Full Text] [Related]
18. On the association between circulating biomarkers and atherosclerotic calcification in a cohort of arterial disease participants. Cahalane RM; Barrett HE; Ross AM; Mulvihill JJE; Purtill H; Selvarajah L; O'Brien J; Kavanagh EG; Moloneye MA; Egan SM; Leahy FC; Griffin TP; Islam MN; O'Shea PM; Walsh MT; O'Connor EM Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1533-1541. PubMed ID: 33810961 [TBL] [Abstract][Full Text] [Related]
19. Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study. Lee SE; Sung JM; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Chun EJ; Conte E; Gottlieb I; Hadamitzky M; Kim YJ; Kumar A; Lee BK; Leipsic JA; Maffei E; Marques H; Pontone G; Raff G; Shin S; Stone PH; Samady H; Virmani R; Narula J; Berman DS; Shaw LJ; Bax JJ; Lin FY; Min JK; Chang HJ Eur Heart J Cardiovasc Imaging; 2019 Nov; 20(11):1307-1314. PubMed ID: 30789215 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Vitamin K-Dependent Proteins in Vascular Calcification. Tesfamariam B J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):323-333. PubMed ID: 30905168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]